Cargando…
Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs
Despite the fact that over 90% of HIV-1 infected people worldwide harbor non-subtype B variants of HIV-1, knowledge of resistance mutations in non-B HIV-1 and their clinical relevance is limited. Due to historical delays in access to antiretroviral therapy (ART) on a worldwide basis, the vast majori...
Autores principales: | Wainberg, Mark A., Brenner, Bluma G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185584/ https://www.ncbi.nlm.nih.gov/pubmed/21994627 http://dx.doi.org/10.3390/v2112493 |
Ejemplares similares
-
The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs
por: Wainberg, Mark A., et al.
Publicado: (2012) -
HIV drug resistance against strand transfer integrase inhibitors
por: Anstett, Kaitlin, et al.
Publicado: (2017) -
Substitutions in the Reverse Transcriptase and Protease Genes of HIV-1 Subtype B in Untreated Individuals and Patients Treated With Antiretroviral Drugs
por: Turner, Dan, et al.
Publicado: (2005) -
HIV-1 subtype C viruses rapidly develop K65R
por: Wainberg, Mark A, et al.
Publicado: (2006) -
Highly diversified multiply drug-resistant HIV-1 quasispecies in PBMCs: a case report
por: Quan, Yudong, et al.
Publicado: (2008)